Refinancing plan unveiled by MultiPlan to strengthen its capital structure

Refinancing plan unveiled by MultiPlan to strengthen its capital structure MultiPlan Corporation (NYSE: MPLN), a prominent provider of technology and data solutions dedicated to cost management, quality improvement, and transparency in healthcare, has announced a comprehensive refinancing initiative. This refinancing…

Read MoreRefinancing plan unveiled by MultiPlan to strengthen its capital structure

Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials

Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials Proton Intelligence Inc., the developer of the innovative Continuous Potassium Monitoring (CKM™) platform, has successfully closed a $6.95 million USD Seed Financing round. The round was supported by investors including…

Read MoreKidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials

Cervical Cancer: NERLYNX® Added to NCCN Guidelines for HER2-Mutation

Cervical Cancer : NERLYNX® Added to NCCN Guidelines for HER2-Mutation Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company focused on advancing cancer treatments, has announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Cervical Cancer have been…

Read MoreCervical Cancer: NERLYNX® Added to NCCN Guidelines for HER2-Mutation

Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor

Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor Encompass Health Corp. (NYSE: EHC) has unveiled plans to construct a new 50-bed, freestanding inpatient rehabilitation hospital in Bangor, Maine, aimed at providing specialized care for patients recovering…

Read MoreHospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor